CDKN1A and ovarian cancer: Another study has verified the tumor antiangiogenesis effects of kaempferol and this flavonoid compound has induced G2/M cell cycle arrest through Chk2/Cdc25C/Cdc2 and Chk2/p21/Cdc2 pathways in A2780/CP70 ovarian cancer cells.